Myriad Genetics Announces First Quarter Fiscal 2005 Financial Results Conference Call; Tuesday, November 9, 2004 at 10:00 a.m. ET

SALT LAKE CITY--(BUSINESS WIRE)--Oct. 26, 2004--Myriad Genetics, Inc. (NASDAQ:MYGN) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, and Greg Critchfield, MD. President of Myriad Genetic Laboratories, Inc.

DATE: November 9, 2004
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173

(Please dial in approximately 10 minutes before the call is scheduled to begin)

A press release will be issued at 6:30 am ET on November 9th. Replay of the call will be available from two hours after the call through November 16th by dialing (800) 642-1687 or (706) 645-9291, and entering conference ID #1770098.

The call will also be available in live audio on the Internet at: www.myriad.com

This call is being webcast by Thomson/CCBN and can be accessed at Myriad's web site at www.myriad.com. The webcast is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

CONTACT: Myriad Genetics, Inc.
Suzanne Barton, 801-584-3840

SOURCE: Myriad Genetics